Sodium-Glucose Cotransporter-2 Inhibitor–Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report
| Autor: | Ashley Fan, Michael C. DiVita, M. Kamath, Roland Davoudi, Beda M. Cha |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Transplantation
2019-20 coronavirus outbreak Diabetic ketoacidosis business.industry Sodium Perioperative Surgical procedures medicine.disease Diabetic Ketoacidosis Prediabetic State Food and drug administration Glucose Diabetes Mellitus Type 2 Anesthesia Heart failure medicine Heart Transplantation Humans Surgery In patient Sodium-Glucose Cotransporter 2 Inhibitor business Sodium-Glucose Transporter 2 Inhibitors |
| Zdroj: | Transplantation Proceedings. 53:2636-2639 |
| ISSN: | 0041-1345 |
| DOI: | 10.1016/j.transproceed.2021.08.017 |
| Popis: | Postoperative euglycemic diabetic ketoacidosis (euDKA) associated with sodium-glucose cotransporter-2 (SGLT2) inhibitor use has been well-documented and carries a Food and Drug Administration recommendation to hold SGLT2 inhibitors 3 to 4 days before a planned surgical procedure. Unfortunately, many surgical procedures, such as orthotopic heart transplant (OHT), are unplanned and unpredictable. With the increasing use of SGLT2 inhibitors in diabetic and non-diabetic heart failure patients, new challenges in patient management and perioperative risk have arisen. We report a case in which SGLT2 inhibitor-associated euDKA complicated the postoperative course of a prediabetic patient who had undergone OHT. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect